Recombinant multi-species NUAK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NUAK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables p53 binding activity and protein serine/threonine kinase activity. Involved in several processes, including protein phosphorylation; regulation of cellular senescence; and regulation of myosin-light-chain-phosphatase activity. Located in cytoplasm; microtubule cytoskeleton; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: NUAK1,NUAK family SNF1-like kinase 1,AMPK-related protein kinase 5 (ARK5), Omphalocele kinase 1,ARK5

Target products collectionGo to NUAK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T21653-Ab-1/ GM-Tg-hg-T21653-Ab-2 Human NUAK1 protein Human
GM-Tg-rg-T21653-Ab-1/ GM-Tg-rg-T21653-Ab-2 Rat NUAK1 protein Rat
GM-Tg-mg-T21653-Ab-1/ GM-Tg-mg-T21653-Ab-2 Mouse NUAK1 protein Mouse
GM-Tg-cynog-T21653-Ab-1/ GM-Tg-cynog-T21653-Ab-2 Cynomolgus/Rhesus macaque NUAK1 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T21653-Ab-1/ GM-Tg-felg-T21653-Ab-2 Feline NUAK1 protein Feline
GM-Tg-cang-T21653-Ab-1/ GM-Tg-cang-T21653-Ab-2 Canine NUAK1 protein Canine
GM-Tg-bovg-T21653-Ab-1/ GM-Tg-bovg-T21653-Ab-2 Bovine NUAK1 protein Bovine
GM-Tg-equg-T21653-Ab-1/ GM-Tg-equg-T21653-Ab-2 Equine NUAK1 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T21653-Ab-1/ GM-Tg-hg-T21653-Ab-2; GM-Tg-rg-T21653-Ab-1/ GM-Tg-rg-T21653-Ab-2;
GM-Tg-mg-T21653-Ab-1/ GM-Tg-mg-T21653-Ab-2; GM-Tg-cynog-T21653-Ab-1/ GM-Tg-cynog-T21653-Ab-2;
GM-Tg-felg-T21653-Ab-1/ GM-Tg-felg-T21653-Ab-2; GM-Tg-cang-T21653-Ab-1/ GM-Tg-cang-T21653-Ab-2;
GM-Tg-bovg-T21653-Ab-1/ GM-Tg-bovg-T21653-Ab-2; GM-Tg-equg-T21653-Ab-1/ GM-Tg-equg-T21653-Ab-2
Products Name NUAK1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NUAK1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NUAK1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.